May 15, 2020
Proteostasis Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
May 13, 2020
Proteostasis Therapeutics to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference
Apr 13, 2020
Proteostasis Therapeutics Announces Completion of Scientific Advice Meeting with the Dutch Medicines Evaluation Board
Mar 10, 2020
Proteostasis Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Corporate Update
Feb 24, 2020
Proteostasis Therapeutics and CF Europe Announce Completion of Patient Enrollment for CHOICES, the First-Ever Personalized Medicine-Based Study in Cystic Fibrosis
Jan 13, 2020
Proteostasis Therapeutics Regulatory Update Following Scientific Advice Meeting with MHRA
Dec 03, 2019
Proteostasis Therapeutics to Present at the Piper Jaffray 31st Annual Healthcare Conference
Nov 07, 2019
Proteostasis Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
Nov 06, 2019
Proteostasis Therapeutics Announces Completion of Enrollment in Global Phase 2 Study in Cystic Fibrosis
Oct 24, 2019
Proteostasis Therapeutics Announces Presentations Highlighting its CFTR Modulators at the North American Cystic Fibrosis Conference
Oct 21, 2019
Proteostasis Therapeutics to Host Cystic Fibrosis Summit on Disparity in Access to CFTR Modulators Based on Geography Featuring Members of the Cystic Fibrosis Community and Thought Leaders
Sep 19, 2019
Proteostasis Therapeutics Announces Presentation at the UK Cystic Fibrosis Conference
Aug 07, 2019
Proteostasis Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
Jul 25, 2019
Proteostasis Therapeutics Initiates Dosing in Global Phase 2 Study in Cystic Fibrosis
Jul 23, 2019
Proteostasis Therapeutics Announces Management Changes and Appointments
Jun 04, 2019
Proteostasis Therapeutics Receives Orphan Drug Designation in the EU for PTI-428 for the Treatment of Cystic Fibrosis
Jun 03, 2019
Proteostasis Therapeutics Announces Presentations and Hosts Educational Symposium at the 42nd European Cystic Fibrosis Conference
May 15, 2019
Proteostasis Therapeutics to Present at the 2019 RBC Capital Markets Global Healthcare Conference
Mar 07, 2019
Proteostasis Therapeutics Appoints David Arkowitz to Board of Directors
Feb 27, 2019
Proteostasis Selected to Join European Consortium to Pioneer Personalized Medicine in Cystic Fibrosis